MSB 8.43% $1.35 mesoblast limited

Up up up down down down, page-48

  1. 30,372 Posts.
    lightbulb Created with Sketch. 1858
    .

    When you've done a study on the background of MSB executives and have something pertinent to say about them, you might get some credibility and relevance.

    Right here right now, it's generalisations 101.

    Still waiting for that study you were claiming to be undertaking on the shorting of biotechs along with an eminent economist (supposedly).

    When pressured on this point, you disappeared for a while. Now you're back, as if nothing had happened (well, it didn't...still waiting).

    You have apparently done next to no research on MSB. Nothing on the science. Nothing on how MSB is perceived to be world leader on stem cell research.

    Nothing. Just generalisations about executives.

    pfft!
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.